NCT07867236Not yet recruiting
Osteogenic Potential of Topical Metformin Gel on Cystic Jaw Defects
Assessment of Osteogenic Potential of Topical Metformin Gel on Bone Regeneration in Cystic Jaw Defects: Randomized Controlled Clinical Trial
Source: ClinicalTrials.gov · Last updated 14 Oct 2026
Brief summary (registry, in English)
Evaluate the osteogenic effect of locally applied 1% metformin gel on bone volume formation after jaw cystic defects enucleation
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- First submitted
- 5 Oct 2026
- Start date
- 30 Oct 2026
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Fayoum University
- NCT number
- NCT07867236
What you commit to
- Study type: Interventional
- Planned participants: 32
- From 30 Oct 2026 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- o Medically compromised patients
- Heavy smokers (consuming more than 10 cigarettes a day).
- Active, acute purulent infection at the surgical site (this must be resolved before surgery).
Who the study is looking for
- o Healthy adults patients .
- Confirmed radiolucent odontogenic cysts requiring enucleation.
- The cystic defect range 5cmto ≤15cm (19)
- Good oral hygiene and strict commitment to attend follow-up scans.
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fayoum University Coordinator of this site? Confirm its status | Al Fayyum | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.